Inhibition of Homologous Recombination and Promotion of Mutagenic Repair of DNA Double-Strand Breaks Underpins Arabinoside–Nucleoside Analogue Radiosensitization

Molecular Cancer Therapeutics - Tập 14 Số 6 - Trang 1424-1433 - 2015
Simon Magin1, Maria Papaioannou1, Janapriya Saha1, Christian Staudt1, George Iliakis1
1Institute of Medical Radiation Biology, University of Duisburg-Essen Medical School, Essen, Germany

Tóm tắt

Abstract In concurrent chemoradiotherapy, drugs are used to sensitize tumors to ionizing radiation. Although a spectrum of indications for simultaneous treatment with drugs and radiation has been defined, the molecular mechanisms underpinning tumor radiosensitization remain incompletely characterized for several such combinations. Here, we investigate the mechanisms of radiosensitization by the arabinoside nucleoside analogue 9-β-D-arabinofuranosyladenine (araA) placing particular emphasis on the repair of DNA double-strand breaks (DSB), and compare the results to those obtained with fludarabine (F-araA) and cytarabine (araC). Postirradiation treatment with araA strongly sensitizes cells to ionizing radiation, but leaves unchanged DSB repair by NHEJ in logarithmically growing cells, in sorted G1 or G2 phase populations, as well as in cells in the plateau phase of growth. Notably, araA strongly inhibits DSB repair by homologous recombination (HRR), as assessed by scoring ionizing radiation–induced RAD51 foci, and in functional assays using integrated reporter constructs. Cells compromised in HRR by RNAi-mediated transient knockdown of RAD51 show markedly reduced radiosensitization after treatment with araA. Remarkably, mutagenic DSB repair compensates for HRR inhibition in araA-treated cells. Compared with araA, F-araA and araC are only modestly radiosensitizing under the conditions examined. We propose that the radiosensitizing potential of nucleoside analogues is linked to their ability to inhibit HRR and concomitantly promote the error-prone processing of DSBs. Our observations pave the way to treatment strategies harnessing the selective inhibitory potential of nucleoside analogues and the development of novel compounds specifically utilizing HRR inhibition as a means of tumor cell radiosensitization. Mol Cancer Ther; 14(6); 1424–33. ©2015 AACR.

Từ khóa


Tài liệu tham khảo

McGinn, 1996, Radiosensitizing nucleosides, J Natl Cancer Inst, 88, 1193, 10.1093/jnci/88.17.1193

Iliakis, 1989, Comparative studies on repair inhibition by araA, araC and aphidicolin of radiation induced DNA and chromosome damage in rodent cells: comparison with fixation of PLD, Int J Radiat Oncol Biol Phys, 16, 1261, 10.1016/0360-3016(89)90295-2

Iliakis, 1985, Evidence for the induction of two types of potentially lethal damage after exposure of plateau phase Chinese hamster V79 cells to γ-rays, Radiat Environ Biophys, 24, 185, 10.1007/BF01209522

Iliakis, 1983, Effects of the nucleoside analogues alpha-ara A, beta-ara A and beta-ara C on cell growth and repair of both potentially lethal damage and DNA double strand breaks in mammalian cells in culture, Anticancer Res, 3, 143

Mustafi, 1994, Enhancement of X-ray toxicity in squamous cell carcinoma cell lines by DNA polymerase inhibitors, Int J Radiat Biol, 65, 675, 10.1080/09553009414550791

Ewald, 2008, Nucleoside analogs: molecular mechanisms signaling cell death, Oncogene, 27, 6522, 10.1038/onc.2008.316

McGinn, 2001, Recent advances in the use of radiosensitizing nucleosides, Semin Radiat Oncol, 11, 270, 10.1053/srao.2001.26002

Mladenov, 2013, DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy, Front Oncol, 3, 113, 10.3389/fonc.2013.00113

Lieber, 2010, The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway, Annu Rev Biochem, 79, 181, 10.1146/annurev.biochem.052308.093131

Mao, 2008, Comparison of nonhomologous end joining and homologous recombination in human cells, DNA Repair, 7, 1765, 10.1016/j.dnarep.2008.06.018

Soni, 2014, Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining, Nucleic Acids Res, 42, 6380, 10.1093/nar/gku298

Xie, 2009, Role of mammalian Mre11 in classical and alternative nonhomologous end joining, Nat Struct Mol Biol, 16, 814, 10.1038/nsmb.1640

Lee-Theilen, 2011, CtIP promotes microhomology-mediated alternative end joining during class-switch recombination, Nat Struct Mol Biol, 18, 75, 10.1038/nsmb.1942

Wu, 2008, Enhanced use of backup pathways of NHEJ in G2 in Chinese hamster mutant cells with defects in the classical pathway of NHEJ, Radiat Res, 170, 512, 10.1667/RR1456.1

Simsek, 2011, DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation, PLoS Genet, 7, e1002080, 10.1371/journal.pgen.1002080

Zhang, 2011, An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway, Nat Struct Mol Biol, 18, 80, 10.1038/nsmb.1940

Wray, 2013, PARP1 is required for chromosomal translocations, Blood, 121, 4359, 10.1182/blood-2012-10-460527

Heyer, 2010, Regulation of homologous recombination in eukaryotes, Annu Rev Genet, 44, 113, 10.1146/annurev-genet-051710-150955

Hinz, 2005, Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells, DNA Repair, 4, 782, 10.1016/j.dnarep.2005.03.005

Qiao, 2013, Imatinib radiosensitizes bladder cancer by targeting homologous recombination, Cancer Res, 73, 1611, 10.1158/0008-5472.CAN-12-1170

Fishman-Lobell, 1992, Two alternative pathways of double-strand break repair that are kinetically separable and independently modulated, Mol Cell Biol, 12, 1292

Stark, 2004, Genetic steps of mammalian homologous repair with distinct mutagenic consequences, Mol Cell Biol, 24, 9305, 10.1128/MCB.24.21.9305-9316.2004

Costantino, 2014, Break-induced replication repair of damaged forks induces genomic duplications in human cells, Science, 343, 88, 10.1126/science.1243211

Shahar, 2012, Live imaging of induced and controlled DNA double-strand break formation reveals extremely low repair by homologous recombination in human cells, Oncogene, 31, 3495, 10.1038/onc.2011.516

Rothkamm, 2003, Pathways of DNA double-strand break repair during the mammalian cell cycle, Mol Cell Biol, 23, 5706, 10.1128/MCB.23.16.5706-5715.2003

Helleday, 2010, Homologous recombination in cancer development, treatment and development of drug resistance, Carcinogenesis, 31, 955, 10.1093/carcin/bgq064

Riballo, 1999, Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient, Curr Biol, 9, 699, 10.1016/S0960-9822(99)80311-X

Gunn, 2012, I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks, Methods Mol Biol, 920, 379, 10.1007/978-1-61779-998-3_27

Bindra, 2013, Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells, Nucleic Acids Res, 41, e115, 10.1093/nar/gkt255

Castro, 2013, High-throughput SNP-based authentication of human cell lines, Int J Cancer, 132, 308, 10.1002/ijc.27675

Iliakis, 1988, Differences in inhibition by beta-arabinofuranosyladenine (araA) of radiation induced DNA damage repair in exponentially growing and plateau-phase CHO-cells, Radiat Environ Biophys, 27, 295, 10.1007/BF01209758

Wang, 2001, Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group, Oncogene, 20, 2212, 10.1038/sj.onc.1204350

Iliakis, 2004, Mechanisms of DNA double strand break repair and chromosome aberration formation, Cytogenet Genome Res, 104, 14, 10.1159/000077461

Ewald, 2007, H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation, Mol Cancer Ther, 6, 1239, 10.1158/1535-7163.MCT-06-0633

Gagou, 2010, Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1, Mol Biol Cell, 21, 739, 10.1091/mbc.e09-07-0618

Raderschall, 1999, Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage, Proc Natl Acad Sci U S A, 96, 1921, 10.1073/pnas.96.5.1921

Scully, 1997, Association of BRCA1 with Rad51 in mitotic and meiotic cells, Cell, 88, 265, 10.1016/S0092-8674(00)81847-4

Gasior, 2001, Assembly of RecA-like recombinases: distinct roles for mediator proteins in mitosis and meiosis, Proc Natl Acad Sci U S A, 98, 8411, 10.1073/pnas.121046198

Tebbs, 1995, Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene, Proc Natl Acad Sci U S A, 92, 6354, 10.1073/pnas.92.14.6354

Feng, 2011, Rad52 inactivation is synthetically lethal with BRCA2 deficiency, Proc Natl Acad Sci U S A, 108, 686, 10.1073/pnas.1010959107

Liu, 2011, Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51, PLoS ONE, 6, e23427, 10.1371/journal.pone.0023427

Short, 2011, Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+tumor-derived cells, Neuro Oncol, 13, 487, 10.1093/neuonc/nor010

Jensen, 2013, BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage, DNA Repair, 12, 306, 10.1016/j.dnarep.2012.12.007

Mozdarani, 1987, The effect of 9-beta-D-arabinofuranosyladenine on the formation of X-ray induced chromatid aberrations in X-irradiated G2 human cells, Mutagenesis, 2, 371, 10.1093/mutage/2.5.371

Wachters, 2003, Selective targeting of homologous DNA recombination repair by gemcitabine, Int J Radiat Oncol Biol Phys, 57, 553, 10.1016/S0360-3016(03)00503-0

Bergs, 2013, Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining, DNA Repair, 12, 38, 10.1016/j.dnarep.2012.10.008

Lepage, 1975, 9-beta-D-arabinofuranosyladenine 5′-phosphate metabolism and excretion in humans, Cancer Res, 35, 3036

Fauvelle, 1991, Diclofenac, paracetamol, and vidarabine removal during plasma exchange in polyarteritis nodosa patients, Biopharm Drug Dispos, 12, 411, 10.1002/bdd.2510120603

Gregoire, 2002, A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma, Radiother Oncol, 63, 187, 10.1016/S0167-8140(02)00024-5

Gandhi, 2002, Cellular and clinical pharmacology of fludarabine, Clin Pharmacokinet, 41, 93, 10.2165/00003088-200241020-00002

Thông tin
Thông tin xuất bản

Molecular Cancer Therapeutics

Tập 14 Số 6

1424-1433

Thông tin tác giả